Psychological Distress in Patients With COPD

Quality of Life Clinical Trial

Official title: The Impact of COPD on Psychological Well-being: A Cross-Sectional Study

Status Not yet recruiting

Clinical Trial Summary

Chronic obstructive pulmonary disease (COPD) can significantly impact a person's quality of life, not only physically but also mentally. This cross-sectional study aims to assess the psychological well-being of COPD patients by utilising specific questionnaires. These questionnaires will evaluate various aspects of mental health, including anxiety, depression, and potentially other relevant factors like self-compassion or fear of negative evaluation, self-efficacy, shame, and guilt. Additionally, the study will examine how these psychological factors relate to the severity of COPD symptoms, such as dyspnea and functional limitations. By understanding the psychological impact of COPD, this research hopes to emphasize the importance of medical education and mental health support in COPD management strategies.

Clinical Trial Description

Chronic obstructive pulmonary disease (COPD) profoundly impacts both physical health and quality of life. Beyond the challenges of breathlessness and functional limitations, COPD patients often struggle with anxiety, depression, and other mental health difficulties at a much higher rate than the general population. This cross-sectional study seeks to understand the current state of psychological well-being in patients with COPD and explore how it relates to the severity of their condition. the study aims to assess the psychological well-being of COPD patients by utilizing specific questionnaires. These questionnaires will evaluate various aspects of mental health, including anxiety, depression, and potentially other relevant factors like self-compassion or fear of negative evaluation, self-efficacy, shame, and guilt. Additionally, the study will examine how these psychological factors relate to the severity of COPD symptoms, such as dyspnea and functional limitations. Investigators will use the following tests: 1. The Hospital Anxiety and Depression Scale (HADS) to identify and measure the severity of anxiety and depression symptoms. 2. The COPD Assessment Test (CAT) to measure the impact of COPD on a person's well-being. 3. The State Shame and Guilt Scale (SSGS) to measure a person's shame and guilt. 4. The Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) to measure the patient's self-efficacy in managing their chronic respiratory disease. 5. The Brief Fear of Negative Evaluation Scale (BFNE) to assess an individual's anxiety around being judged or criticized by others. 6. The Self-Compassion Scale Short Form (SCS-SF) to measure key components of self-compassion. 7. The mMRC scale to evaluate the patient's level of breathlessness (dyspnea) in everyday life. 8. The six-minute walking test (6MWT) to measure how far a person can walk on a flat, hard surface in six minutes. ;

Related Conditions & MeSH terms

• COPD
• Mental Health
• Psychological Distress
• Quality of Life

• NCT number: NCT06395311
• Study type: Observational
• Source: Spitalul Clinic de Boli Infec?ioase ?i Pneumoftiziologie Dr. Victor Babe? Timi?oara
• Contact: Alexandru Cri?an, PhD
• Phone: 0765525688
• Email: crisan@umft.ro
• Status: Not yet recruiting
• Start date: May 13, 2024
• Completion date: November 30, 2024